Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

ARWRARWR
Showing 7 of 22 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in ARROWHEAD PHARMACEUTICALS IN

Janus Henderson Group Ltd. holds 1.4M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $90.1M as of 2026-Q1. The position was increased (+12.2% shares). ARWR represents 0.0% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$90.1M

Current Shares

1.4M

Total Value Change

+$89.2M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.4M
+12.2%
$90.1M0.0%$64.10
33
2025-Q4
Increased
1.3M
+31.5%
$85M0.0%$67.25
38
2025-Q3
Increased
973,567
+1853.2%
$33.5M0.0%$33.78
47
2025-Q2
Unchanged
49,845
0.0%
$787,8000.0%$16.08
0
2025-Q1
Unchanged
49,845
0.0%
$688,6090.0%$13.82
0
2024-Q4
Unchanged
49,845
0.0%
$936,8370.0%$18.61
0
2024-Q3
Decreased
49,845
-12.3%
$964,9990.0%$19.67
0

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used